APA (7th ed.) Citation

Adam, J., Sourisseau, T., Olaussen, K. A., Robin, A., Zhu, C. Q., Templier, A., . . . Besse, B. (2016). MMS19 as a potential predictive marker of adjuvant chemotherapy benefit in resected non-small cell lung cancer. Cancer Biomarkers, 17(3), 323. https://doi.org/10.3233/CBM-160644

Chicago Style (17th ed.) Citation

Adam, Julien, et al. "MMS19 as a Potential Predictive Marker of Adjuvant Chemotherapy Benefit in Resected Non-small Cell Lung Cancer." Cancer Biomarkers 17, no. 3 (2016): 323. https://doi.org/10.3233/CBM-160644.

MLA (9th ed.) Citation

Adam, Julien, et al. "MMS19 as a Potential Predictive Marker of Adjuvant Chemotherapy Benefit in Resected Non-small Cell Lung Cancer." Cancer Biomarkers, vol. 17, no. 3, 2016, p. 323, https://doi.org/10.3233/CBM-160644.